The PI3 Kinase Signaling Pathway in Prostate Cancer

被引：0
|
作者：
Elfiky, Aymen A. [1 ]
Jiang, Zhenyang [1 ]
机构：
[1] Harvard Univ, Sch Med, Dana Farber Canc Inst, Lank Ctr Genitourinary Oncol, Boston, MA 02115 USA
来源：
CURRENT CANCER DRUG TARGETS | 2013年 / 13卷 / 02期
关键词：
Androgen receptor; mammalian target of rapamycin; phosphatidylinositol; 3-kinase; prostate cancer; PTEN; ANDROGEN RECEPTOR FUNCTION; PTEN GENOMIC DELETION; 4-PHOSPHATASE TYPE-II; TRANSCRIPTION FACTORS; TUMOR-SUPPRESSOR; HORMONAL-THERAPY; CELL-POPULATIONS; FISH ANALYSIS; MTOR COMPLEX; GENE FUSIONS;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Despite recent advances in our understanding of the biological basis of prostate cancer, the management of the disease, especially in the castration-resistant phase, remains a significant challenge. Deregulation of the phosphatidylinositol 3-kinase (PI3K) pathway is increasingly implicated in a number of malignancies, including prostate carcinogenesis. In this review, we detail the role of this pathway in the pathogenesis of prostate cancer and the therapeutic implications of targeting it.
引用
收藏
页码：157 / 164
页数：8
相关论文
共 50 条
  • [1] PI3 kinase integrates Akt and MAP kinase signaling pathways in the regulation of prostate cancer
    Goc, Anna
    Al-Husein, Belal
    Kochuparambil, Samith T.
    Liu, Junxiu
    Heston, Warren W. D.
    Somanath, Payaningal R.
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2011, 38 (01) : 267 - 277
  • [2] Targeting PI3 kinase in cancer
    Bauer, Todd M.
    Patel, Manish R.
    Infante, Jeffrey R.
    PHARMACOLOGY & THERAPEUTICS, 2015, 146 : 53 - 60
  • [3] The Association of PI3 Kinase Signaling and Chemoresistance in Advanced Ovarian Cancer
    Carden, Craig P.
    Stewart, Adam
    Thavasu, Parames
    Kipps, Emma
    Pope, Lorna
    Crespo, Mateus
    Miranda, Susana
    Attard, Gerhardt
    Garrett, Michelle D.
    Clarke, Paul A.
    Workman, Paul
    de Bono, Johann S.
    Gore, Martin
    Kaye, Stan B.
    Banerji, Udai
    MOLECULAR CANCER THERAPEUTICS, 2012, 11 (07) : 1609 - 1617
  • [4] AR Signaling and the PI3K Pathway in Prostate Cancer
    Crumbaker, Megan
    Khoja, Leila
    Joshua, Anthony M.
    CANCERS, 2017, 9 (04):
  • [5] Neuroprotective Role of the PI3 Kinase/Akt Signalling Pathway in Zebrafish
    Chen, Shuang
    Liu, Yunzhang
    Rong, Xiaozhi
    Li, Yun
    Zhou, Jianfeng
    Lu, Ling
    FRONTIERS IN ENDOCRINOLOGY, 2017, 8
  • [6] Should individual PI3 kinase isoforms be targeted in cancer?
    Jia, Shidong
    Roberts, Thomas M.
    Zhao, Jean J.
    CURRENT OPINION IN CELL BIOLOGY, 2009, 21 (02) : 199 - 208
  • [7] PTEN and the PI3-Kinase Pathway in Cancer
    Chalhoub, Nader
    Baker, Suzanne J.
    ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE, 2009, 4 : 127 - 150
  • [8] Expression of TGFβ3 and its effects on migratory and invasive behavior of prostate cancer cells: involvement of PI3-kinase/AKT signaling pathway
    Walker, Lindsey
    Millena, Ana C.
    Strong, Nicole
    Khan, Shafiq A.
    CLINICAL & EXPERIMENTAL METASTASIS, 2013, 30 (01) : 13 - 23
  • [9] Comprehensive analysis of T cell leukemia signals reveals heterogeneity in the PI3 kinase-Akt pathway and limitations of PI3 kinase inhibitors as monotherapy
    Ksionda, Olga
    Mues, Marsilius
    Wandler, Anica M.
    Donker, Lisa
    Tenhagen, Milou
    Jun, Jesse
    Ducker, Gregory S.
    Matlawska-Wasowska, Ksenia
    Shannon, Kevin
    Shokat, Kevan M.
    Roose, Jeroen P.
    PLOS ONE, 2018, 13 (05):
  • [10] Targeting the PI3-Kinase/Akt/mTOR Signaling Pathway
    Hassan, Burhan
    Akcakanat, Argun
    Holder, Ashley M.
    Meric-Bernstam, Funda
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2013, 22 (04) : 641 - +
12345